A Study of Abemaciclib (LY2835219) Plus Tamoxifen or Abemaciclib Alone in Women With Metastatic Breast Cancer

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

234

Participants

Timeline

Start Date

September 14, 2016

Primary Completion Date

June 15, 2018

Study Completion Date

December 31, 2025

Conditions
Metastatic Breast Cancer
Interventions
DRUG

Abemaciclib

Administered orally

DRUG

Tamoxifen

Administered orally

DRUG

Prophylactic Loperamide

Administered orally

Trial Locations (59)

235

Taipei Medical University Shuang Ho Hospital, New Taipei City

1090

AKH, Vienna

1250

Baskent University Dr. Turgut Noyan Research and Training Center, Adana

4000

Centro Para la Atención Integral del Paciente Oncologico (CAIPO), San Miguel de Tucumán

Centre Hospitalier Universitaire Sart Tilman, Liège

4400

Sanatorio Parque, Salta

6000

Grand Hopital de Charleroi-Site Notre-Dame, Charleroi

6020

Universitätsklinik Innsbruck, Innsbruck

8036

Medizinische Universitaet Graz, Graz

9000

Universitair Ziekenhuis Gent, Ghent

9100

VITAZ, Sint-Niklaas

10449

Mackay Memorial Hospital, Taipei

11217

Taipei Veterans General Hospital, Taipei

13273

Institut Paoli-Calmettes, Marseille

22087

Kath. Marienkrankenhaus gGmbH, Hamburg

28007

Hospital General Universitario Gregorio Marañon, Madrid

28034

Hospital Universitario Ramón y Cajal, Madrid

28040

Hospital Clinico San Carlos, Madrid

28041

Hospital Universitario 12 de Octubre, Madrid

33305

Chang Gung Memorial Hospital - Linkou, Taoyuan

34214

Medipol Mega University Hospital, Istanbul

34668

Marmara University Medical Faculty, Istanbul

37024

Ospedale Sacro Cuore Don G. Calabria, Negrar Di Valpolicella

37203

Tennessee Oncology PLLC, Nashville

38039

Erciyes University Faculty of Medicine, Kayseri

40139

Ospedale Bellaria - Azienda USL di Bologna, Bologna

40447

China Medical University Hospital, Taichung

46010

Hospital Clínico Universitario de Valencia, Valencia

50080

Centro Hemato Oncologico Privado, San Bernardino

53705

University of Wisconsin Clinical Research Center, Madison

59020

Centre Oscar Lambret, Lille

68000

Oaxaca Site Management Organization, Oaxaca City

76104

The Center for Cancer and Blood Disorders, Fort Worth

80020

Neurociencias Estudios Clinicos, Culiacán

80131

Azienda Ospedaliera Universitaria Federico II, Napoli

85724

The University of Arizona Cancer Center, Tucson

89081

Universitätsklinikum Ulm, Ulm

197758

St-Petersburg scientifical practical center of specialized medical care, Saint Petersburg

198255

Saint-Petersburg city clinical oncology dispensary, Saint Petersburg

420029

Republic Oncology Dispensary of MoH of Republic Tatarstan, Kazan'

14784400

Fundação Pio XII - Hospital de Câncer de Barretos, Barretos

03766

Dartmouth Hitchcock Medical Center, Lebanon

C1125ABD

CENIT Centro de Neurociencias, Investigación y Tratamiento, CABA

Y4600APW

Fundacion Ars Medica, San Salvador de Jujuy

R8500ACE

Clinica Viedma, Viedma

S2000KZE

Instituto de Oncología de Rosario, Rosario

90610-000

Hospital São Lucas - PUCRS - ONCOLOGY, Porto Alegre

01246000

Icesp - Instituto Do Câncer Do Estado de São Paulo, São Paulo

01317-000

Clinica de Pesquisas e Centro de Estudos em Oncologia Ginecológica e Mamária LTDA, São Paulo

656 53

Masarykuv onkologicky ustav, Brno

100 34

Fakultni nemocnice Kralovske Vinohrady, Prague

128 08

Fakultni Poliklinika VFN, Prague

150 06

Fakultni Nemocnice v Motole, Prague

140 59

Thomayerova nemocnice, Praha 4 - Krc

00161

Polic.Umberto I -Univ. La Sapienza, Roma

03310

Grupo Medico Camino Sc, Mexico City

08035

Hospital Universitari Vall d'Hebron, Barcelona

08036

Hospital Clinic I Provincial, Barcelona

06100

Hacettepe University Faculty of Medicine, Ankara

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY